
    
      All subjects enrolled from Eastern United States and Eastern Canada will continue their
      participation in the pilot efficacy follow-up (pilot efficacy subset).

      The third dose of IPV vaccine (IPOL) may be given at visit 3, 4 or another time, at the
      investigator's discretion.

      Comvax may be given in place of OmniHIB/ActHIB at Visit 1 and Visit 2 and the third dose of
      Comvax administered according to the prescribing information.
    
  